ANI Pharmaceuticals, Inc. (ANIP)
81.67
+0.33
(+0.41%)
USD |
NASDAQ |
Dec 09, 16:00
81.64
-0.03
(-0.04%)
After-Hours: 20:00
ANI Pharmaceuticals Profit Margin (Quarterly): 10.59% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| CorMedix, Inc. | -- |
| Arcutis Biotherapeutics, Inc. | 7.47% |
| Intellia Therapeutics, Inc. | -735.2% |
| Beam Therapeutics, Inc. | -1.16K% |
| Halozyme Therapeutics, Inc. | 49.46% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 8.22% |
| Return on Assets | 2.70% |
| Return on Invested Capital | 3.30% |
| Gross Profit Margin (Quarterly) | 49.07% |
| Operating Margin (Quarterly) | 10.02% |
| Return on Net Operating Assets | 3.13% |